Insider Transactions in Q4 2023 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2023
|
Samraat S. Raha Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236,360
+50.0%
|
-
|
|
Dec 01
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-9.32%
|
$570,000
$19.09 P/Share
|
|
Nov 01
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.53%
|
$450,000
$15.69 P/Share
|
|
Oct 18
2023
|
Pamela Wong Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,309
-2.31%
|
$49,635
$15.06 P/Share
|
|
Oct 09
2023
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,366
-1.63%
|
$125,490
$15.01 P/Share
|
|
Oct 09
2023
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,336
-1.71%
|
$185,040
$15.01 P/Share
|
|
Oct 09
2023
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308
-0.45%
|
$4,620
$15.01 P/Share
|
|
Oct 09
2023
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,710
-1.59%
|
$25,650
$15.01 P/Share
|
|
Oct 09
2023
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,111
-2.6%
|
$181,665
$15.01 P/Share
|